Hochuekkito for Long COVID and ME/CFS: What the Evidence Really Shows
A clear review of Hochuekkito, an influenza cell study, and a 2023 case report of a 55-year-old woman with Long COVID meeting ME/CFS criteria.
A clear review of Hochuekkito, an influenza cell study, and a 2023 case report of a 55-year-old woman with Long COVID meeting ME/CFS criteria.
A clear fact-check of the viral claim that a Leiden study cured ME/CFS by restoring Faecalibacterium prausnitzii, and what science actually says.